Evolocumab Reduces Oxidative Stress and Lipid Peroxidation in Obese Zucker Rats
<b>Background/Objectives</b>: Evolocumab inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) binding to low-density lipoprotein (LDL) receptors, thus allowing more LDL receptors to remove LDL cholesterol from the blood. We aimed to determine the effects of evolocumab on the pl...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pathophysiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1873-149X/32/1/5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|